LumiThera Presents US LIGHTSITE III Trial Data Showing Improvement in Vision in Intermediate Dry...
WCTV Tallahassee· 5 days agoLumiThera Inc., a commercial stage medical device company offering photobiomodulation (PBM) treatment for ocular damage and disease, today announced detailed findings in its ...
NGM Biopharmaceuticals: Eye Disorder Data Due 2nd Half Of 2022 (NASDAQ:NGM)
Seeking Alpha· 5 days agoThis will be the release of results from the phase 2 CATALINA study using NGM621 for the treatment...
Kinarus Therapeutics to host KOL event on Monday, June 27, to discuss therapies in wet Age-Related ...
Morningstar· 3 days agoKinarus Therapeutics to host KOL event on Monday, June 27, to discuss therapies in wet Age-Related Macular Degeneration and potential advantages of KIN001 ...
Cost of ranibizumab port delivery system for treating nAMD examined
Medical Xpress· 3 days agoFor patients with neovascular age-related macular degeneration (nAMD), ranibizumab with a port...
Adverum Biotechnologies Obtains EMA’s Priority Medicines Status For Chronic Eye Disorder Candidate -...
Benzinga· 2 days agoThe European Medicines Agency (EMA) has granted Priority Medicines (PRIME) designation to Adverum Biotechnologies’ ADVM lead drug ADVM-022 for the treatment of wet age-related ...
Apellis (APLS) Expands Deal for Targeted Complement Therapies
Zacks via Yahoo Finance· 3 days agoApellis (APLS) expands its current research and development deal with privately held company,...
EyePoint Pharmaceuticals Announces Election of Tony Adamis, M.D. to Board of Directors
Morningstar· 3 days agoDr. Adamis is a highly accomplished ophthalmology executive with more than 30 years of research and development experience in the biopharmaceutical industry. “Dr. Adamis is a pioneer in the ...
Vision Forward raising awareness of services for blind, visually impaired
The Journal Times· 7 hours agoThe number of Americans ages 40 and over with blindness or visual impairment is expected to double...
Vision changes after 40? Here's what you need to know
The Port Lavaca Wave· 2 days agoThe American Academy of Ophthalmology (AAO) suggests everyone see an ophthalmologist for a baseline eye disease screening at age 40, even if there are no apparent problems with their vision.
Supplements warning: The vitamin linked to a ‘rapid' reduction in vision ‘over minutes'
MSN News· 2 days agoUNLIKE drugs, supplements are not intended to treat, prevent or cure diseases, but instead are...
Yahoo Web Search
Trending Now
